Navigation Links
Global Cervical Artificial Disc Market to Hit $1 Billion by 2012
Date:3/18/2008

Global cervical artificial disc market will see a compound annual growth rate of 65% from 2008 through 2012, according to Millennium Research Group

WALTHAM, Mass., March 18 /PRNewswire/ -- According to Millennium Research Group's (MRG) Global Markets for Spinal Nonfusion Technologies 2008 report, which covers markets in the US, Europe, and Asia Pacific regions, the global cervical artificial disc market will grow from a value of just under $60 million in 2007 to approximately $1 billion in 2012.

Several factors will be integral in facilitating growth in this market, including increased adoption of Synthes Spine's and Medtronic Spinal and Biologics' cervical artificial discs in the US, the release of newly designed products from numerous different competitors, a familiar surgical approach to that of anterior cervical fusion, as well as an increased use of multiple discs in a single procedure.

"Both patients and surgeons alike are excited about cervical artificial disc technology," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "Patients benefit from the increased motion preservation associated with cervical artificial discs, as well as the shorter recovery times, which enables them to return quickly to their regular lifestyles. Surgeons, on the other hand, are comfortable with the surgical technique and are attracted by the technologies' ability to restore physiological motion and minimize adjacent-level disc disease."

The Global Markets for Spinal Nonfusion Technologies 2008 report covers the artificial disc, dynamic stabilization, nuclear disc replacement, annulus repair, and facet arthroplasty markets. Industry competitors include Abbott Spine, Aesculap Implant Systems, Anulex Technologies, Biomet Spine, Cervitech, DePuy Spine, LDR Spine, Medtronic Spinal and Biologics/Kyphon, NuVasive, Paradigm Spine, Raymedica, Scient'x, SpineVision, Stryker Spine, Synthes Spine, Trans1, and Zimmer Spine.

About Cervical Artificial Discs

With age, intervertebral discs may begin to dehydrate and lose their ability to retain water, contributing to severe pain and decreased mobility. Artificial discs were developed to treat chronic back pain while allowing for the preservation of physiological vertebral motion through proper intervertebral spacing and stability.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Winners Announced in HopeLabs Global Competition to Get Kids Moving!
2. West Pharmaceutical Services to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
3. Robotic Surgeons From Around the World Attend One-of-a-Kind Conference by Global Robotics Institute at Florida Hospital
4. Exelixis Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
5. Murad, Inc., Hires Lori Jacobus as Vice President of Global Marketing
6. Brookdale to Present at Lehman Global Healthcare Conference on March 19
7. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
8. Accordia Global Health Foundation Convenes Inaugural Infectious Diseases Summit
9. First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide
10. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
11. Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , ... March 24, 2017 , ... ... which will spark a conversation on the current obstacles facing infection prevention and ... completely preventable deaths caused by these infections. , The print component of ...
(Date:3/24/2017)... ... 24, 2017 , ... Digital Scientists, a software innovation lab specializing in web ... Greenville, South Carolina location. The lab has set up shop at the ... working with South Carolina clients for years from our office here in Atlanta,” explains ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study ... because it does not obey the rules Congress has directed the CBO to follow. ... the GOP reform would restore. Yet, it estimates a reduction in employer-based coverage due ...
(Date:3/24/2017)... ... ... The iaedp Foundation, the premier provider of educational programs and training standards for ... spectrum of disordered eating, announced today that the 2017 Symposium set a new attendance ... several countries converged on the Green Valley Resort in Las Vegas. , “We ...
(Date:3/24/2017)... ... 2017 , ... Shamanic healer and teacher Anahata Ananda of ... Awakening, proudly presents her Sacred Peru retreat with world famous shaman and ... during the Summer Solstice will also be her final international retreat, Anahata announced ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...  Eli Lilly and Company (NYSE: ... million in its U.S. operations in 2017. The ... including research laboratories, manufacturing sites, and general and ... demand for Lilly products, as well as its ... cancer, pain, diabetes and other unmet medical needs.  ...
(Date:3/24/2017)... 23, 2017  Mirabilis Medical, a ... for non-invasive surgery, announced today CE Mark authorization ... of uterine fibroids throughout the European Union.  The ... from the US Food and Drug Administration to ... in the United States.  The Mirabilis System combines ...
(Date:3/24/2017)... and GENEVA , March ... on World Tuberculosis Day revitalizes efforts to develop sutezolid ... On World Tuberculosis Day, TB Alliance and the ... the clinical development of sutezolid, an antibiotic drug candidate ... pertains to the development of sutezolid in combination with ...
Breaking Medicine Technology: